Literature DB >> 20564533

Successful use of infliximab for perianal Crohn's disease in pregnancy.

Maria Chaparro, Javier P Gisbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 20564533     DOI： 10.1002/ibd.21368

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  4 in total

1.  Safety of Tumor Necrosis Factor Inhibitors during Pregnancy and Breastfeeding.

Authors:  Harish Raja; Eric L Matteson; Clement J Michet; Justine R Smith; Jose S Pulido
Journal:  Transl Vis Sci Technol       Date:  2012-09-21       Impact factor: 3.283

Review 2.  Tumor necrosis factor-α inhibitor therapy and fetal risk: a systematic literature review.

Authors:  Renée M Marchioni; Gary R Lichtenstein
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

Review 3.  Safety of TNF-α inhibitors during IBD pregnancy: a systematic review.

Authors:  Ole Haagen Nielsen; Edward V Loftus; Tine Jess
Journal:  BMC Med       Date:  2013-07-31       Impact factor: 8.775

Review 4.  Insights into the treatment of inflammatory bowel disease in pregnancy.

Authors:  Sarah E Shannahan; Jonathan M Erlich; Mark A Peppercorn
Journal:  Therap Adv Gastroenterol       Date:  2019-05-27       Impact factor: 4.409
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.